Longitudinal changes in radiographic features of pulmonary Mycobacterium avium complex diseases

被引:2
|
作者
Watanabe, Chie [1 ]
Suematsu, Ryohei [1 ]
Sano, Tomoya [1 ]
Hamamoto, Takaaki [2 ]
Maki, Yohei [1 ]
Ito, Koki [1 ]
Sugiura, Hiroaki [3 ]
Shinmoto, Hiroshi [3 ]
Kawana, Akihiko [1 ]
Kimizuka, Yoshifumi [1 ,4 ]
机构
[1] Natl Def Med Coll, Dept Internal Med, Div Infect Dis & Resp Med, Saitama, Japan
[2] Natl Def Med Coll Hosp, Dept Clin Lab, Saitama, Japan
[3] Natl Def Med Coll, Dept Radiol, Saitama, Japan
[4] Natl Def Med Coll, Dept Internal Med, Div Infect Dis & Resp Med, 3-2 Namiki, Saitama 3598513, Japan
关键词
Nontuberculous mycobacteria; Computed tomography; Mixed-effects model; Reversible lesions; Irreversible lesions; EPIDEMIOLOGY; PREVALENCE; CT;
D O I
10.1016/j.heliyon.2023.e18967
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: The radiographic features of Mycobacterium avium complex pulmonary disease (MAC-PD), a major component of nontuberculous mycobacteria, consist of a variety of lesions; however, the responsiveness of each type of radiographic factor to treatment is unclear. Thus, we evaluated the longitudinal changes of each factor in serial computed tomography (CT) images using a mixed-effects model, and investigated the radiographic transition in patients with MAC-PD whose progress could be followed.Methods: In this retrospective study, eighty-four patients diagnosed with MAC-PD and with yearly CT records were recruited after a review of 328 medical records with culture-positive MAC in respiratory specimens. The study participants were divided into two groups: treatment (n = 43) and no-treatment (n = 41) groups. Radiographic images were scored using the nodule (N), infiltration (I), cavity (C), ectasis (E) scoring system. Longitudinal changes in each radiographic lesion factor were analyzed using a mixed-effects model in treated and untreated patients.Results: All factors tended to progress without treatment, and significant longitudinal changes were observed in the N, I, and E factors (N: p = 0.010, I: p = 0.004, E: p < 0.001). Although treatment tended to improve N and I in radiographic images (N: p = 0.006, I: p = 0.203), cavities and ectasis progressed, regardless of treatment (C: p = 0.057 and E: p = 0.033).Conclusion: Radiographic changes of MAC-PD can be categorized into reversible (nodules and infiltrations) and irreversible (cavities and ectasis) lesions. Early treatment may prevent the accumulation of irreversible factors.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Treatment for Mycobacterium avium complex lung disease
    Pan, Sheng-Wei
    Shu, Chin-Chung
    Feng, Jia-Yih
    Su, Wei-Juin
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2020, 119 : S67 - S75
  • [42] Analysis of chest CT in patients with Mycobacterium avium complex pulmonary disease
    Fujiuchi, S
    Matsumoto, H
    Yamazaki, Y
    Nakao, S
    Takahashi, M
    Satoh, K
    Takeda, A
    Okamoto, K
    Fujita, Y
    Fujikane, T
    Shimizu, T
    RESPIRATION, 2003, 70 (01) : 76 - 81
  • [43] Role of ethambutol and rifampicin in the treatment of Mycobacterium avium complex pulmonary disease
    Kim, Hyung-Jun
    Lee, Jong Sik
    Kwak, Nakwon
    Cho, Jaeyoung
    Lee, Chang-Hoon
    Han, Sung Koo
    Yim, Jae-Joon
    BMC PULMONARY MEDICINE, 2019, 19 (01)
  • [44] Association between Mycobacterium avium Complex Pulmonary Disease and Mycobacteria in Home Water and Soil A Case-Control Study
    Tzou, Connie L.
    Dirac, M. Ashworth
    Becker, Annie L.
    Beck, Nicola K.
    Weigel, Kris M.
    Meschke, John S.
    Cangelosi, Gerard A.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2020, 17 (01) : 57 - 62
  • [45] Evaluation of Mycobacterium Avium Complex Pulmonary Disease Treatment Completion and Adherence to ATS/IDSA Guidelines
    Ku, Jennifer H.
    Henkle, Emily
    Carlson, Kathleen F.
    Marino, Miguel
    Brode, Sarah K.
    Marras, Theodore K.
    Winthrop, Kevin L.
    CLINICAL INFECTIOUS DISEASES, 2023, 76 (03) : E1408 - E1415
  • [46] SERUM GLYCOPEPTIDOLIPID CORE IgA ANTIBODY LEVELS IN PATIENTS WITH CHEST COMPUTED TOMOGRAPHY FEATURES OF MYCOBACTERIUM AVIUM-INTRACELLULARE COMPLEX PULMONARY DISEASE
    Shimizu, Y.
    Takise, A.
    Morita, H.
    Hosomi, Y.
    Kasahara, N.
    Kawata, T.
    Horie, T.
    Ishii, Y.
    Yamada, M.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2014, 28 (03) : 399 - 405
  • [47] Management of Mycobacterium avium complex and Mycobacterium abscessus pulmonary disease: therapeutic advances and emerging treatments
    Kumar, Kartik
    Daley, Charles L.
    Griffith, David E.
    Loebinger, Michael R.
    EUROPEAN RESPIRATORY REVIEW, 2022, 31 (163)
  • [48] Comparison of Clinical Features, Virulence, and Relapse among Mycobacterium avium Complex Species
    Boyle, Daniel P.
    Zembower, Teresa R.
    Reddy, Susheel
    Qi, Chao
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191 (11) : 1310 - 1317
  • [49] Treatment outcomes of Mycobacterium avium complex pulmonary disease according to disease severity
    Kim, Bo-Guen
    Jhun, Byung Woo
    Kim, Hojoong
    Kwon, O. Jung
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [50] Use of Anti-Glycopeptidolipid-Core Antibodies Serology for Diagnosis and Monitoring of Mycobacterium avium Complex Pulmonary Disease in the United States
    Hernandez, A. G.
    Brunton, A. E.
    Ato, M.
    Morimoto, K.
    Machida, S.
    Henkle, E.
    Winthrop, K. L.
    OPEN FORUM INFECTIOUS DISEASES, 2022, 9 (11):